Literature DB >> 22911278

Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span.

Arunangshu Das1, James D Bortner, Cesar A Aliaga, Aaron Baker, Anne Stanley, Bruce A Stanley, Matthew Kaag, John P Richie, Karam El-Bayoumy.   

Abstract

BACKGROUND: Aging-related changes in important cellular pathways in the prostate may promote a permissive environment for an increased risk for prostatic disease development such as prostate cancer. Our objectives were to examine for such changes, by systematically determining the effects of growth and development and aging on proteomic profiles in different lobes of the rat prostate.
METHODS: Prostate lobes (dorsolateral lobe, DL and ventral lobe, VL) were obtained from male Fisher rats of various ages representing young (4 months), mature (12 months), old (18 months), and very old (24 months). Differentially expressed proteins between age groups in each lobe were identified using a proteomic approach, isobaric Tags for Relative and Absolute Quantitation (iTRAQ). Select changes in the DL and VL were verified by immunoblot analysis.
RESULTS: iTRAQ identified 317 proteins with high confidence. iTRAQ discovered 12 and 6 proteins significantly modulated in response to growth and development in the DL and VL, respectively, and 42 and 29 proteins significantly modulated in response to aging in the DL and VL, respectively. Proteins modulated during growth and development in the DL and VL are involved in a variety of biological processes including cell communication and development, whereas proteins modulated during aging were predominantly related to antioxidant activity and immunity. Immunoblot analysis verified age-related changes for α-1 antitrypsin, annexin A1, hypoxia up-regulated protein 1, and 78 kDa glucose-regulated protein.
CONCLUSIONS: Aging results in changes in numerous prostatic proteins and pathways which are mainly linked to inflammation and may lead to prostatic disease development.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22911278      PMCID: PMC3556222          DOI: 10.1002/pros.22576

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  66 in total

1.  Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age.

Authors:  S Banerjee; P P Banerjee; T R Brown
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

2.  Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.

Authors:  Jinhui Zhang; Lei Wang; Lorraine B Anderson; Bruce Witthuhn; Yanji Xu; Junxuan Lü
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-20

3.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.

Authors:  Sung-Yup Cho; Kyungho Choi; Ju-Hong Jeon; Chai-Wan Kim; Dong-Myung Shin; Jong Bouk Lee; Sang Eun Lee; Choung-Soo Kim; Jeong-Soo Park; Eui Man Jeong; Gi-Yong Jang; Kye-Yong Song; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2010-04-30       Impact factor: 8.718

5.  Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking.

Authors:  James D Bortner; John P Richie; Arunangshu Das; Jason Liao; Todd M Umstead; Anne Stanley; Bruce A Stanley; Chandra P Belani; Karam El-Bayoumy
Journal:  J Proteome Res       Date:  2011-02-07       Impact factor: 4.466

6.  CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro.

Authors:  Lesa Begley; Christine Monteleon; Rajal B Shah; James W Macdonald; Jill A Macoska
Journal:  Aging Cell       Date:  2005-12       Impact factor: 9.304

7.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines.

Authors:  D K Ornstein; J W Gillespie; C P Paweletz; P H Duray; J Herring; C D Vocke; S L Topalian; D G Bostwick; W M Linehan; E F Petricoin; M R Emmert-Buck
Journal:  Electrophoresis       Date:  2000-06       Impact factor: 3.535

8.  Age-related radical-induced DNA damage is linked to prostate cancer.

Authors:  D C Malins; P M Johnson; T M Wheeler; E A Barker; N L Polissar; M A Vinson
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

9.  Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer.

Authors:  G An; C S Meka; S P Bright; R W Veltri
Journal:  Urology       Date:  1999-12       Impact factor: 2.649

10.  The effects of aging on the molecular and cellular composition of the prostate microenvironment.

Authors:  Daniella Bianchi-Frias; Funda Vakar-Lopez; Ilsa M Coleman; Stephen R Plymate; May J Reed; Peter S Nelson
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

View more
  2 in total

1.  Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2013-02-10

Review 2.  Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.

Authors:  Gianluigi Taverna; Mauro Seveso; Guido Giusti; Rodolfo Hurle; Pierpaolo Graziotti; Sanja Stifter; Maurizio Chiriva-Internati; Fabio Grizzi
Journal:  Curr Gerontol Geriatr Res       Date:  2014-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.